Carrier Is Inorganic Patents (Class 436/524)
-
Patent number: 8481334Abstract: The invention features a method of attaching a ligand that has a free carboxyl group to a solid support by adding an amino group to the ligand to form a ligand-amino derivative, converting the ligand amino derivative to a ligand sulfhydryl derivative, attaching the ligand sulfhydryl derivative to a protein to form a ligand-linker-protein conjugate, and applying the ligand-linker-protein conjugate to the solid support. The method is particularly useful for immobilizing small molecule ligands having a free carboxyl group, such as cloxicillin, to a lateral-flow test strip, in order to make a detection zone on the test strip that exhibits a clear signal and enhanced sensitivity.Type: GrantFiled: March 31, 2008Date of Patent: July 9, 2013Assignee: Charm Sciences, Inc.Inventor: Steven J. Saul
-
Patent number: 8476083Abstract: Described herein is a time-gated, two-step FRET relay effective to provide temporal transference of a prompt FRET pathway, or provide spectro-temporal encoding analytical signals and other information. A FRET relay assembly includes a long lifetime FRET donor (for example, a lanthanide complex), a semiconductor quantum dot (QD) configured as an intermediate acceptor/donor in FRET, and a fluorescent dye configured as a terminal FRET acceptor, wherein the long lifetime FRET donor has an excited state lifetime of at least one microsecond and the QD and fluorescent dye each have excited state lifetimes of less than 100 nanoseconds.Type: GrantFiled: May 18, 2012Date of Patent: July 2, 2013Assignee: The United States of America, as represented by the Secretary of the NavyInventors: W. Russ Algar, Niko Hildebrandt, Alan L Huston, Igor L. Medintz
-
Patent number: 8476079Abstract: Methods and devices for reducing interference from leukocytes in an analyte immunoassay are provided. In one embodiment, a method is provided comprising the steps of amending a biological sample such as a whole blood sample with one or more leukocidal reagents that reduce or eliminate the metabolic activity of leukocytes, and performing an immunoassay on the amended sample to determine the concentration of analyte in the sample. Preferably, the sample is amended with one or more enzymes and optionally one or more enzyme substrates and cofactors.Type: GrantFiled: April 30, 2010Date of Patent: July 2, 2013Assignee: Abbott Point of Care Inc.Inventors: John Lewis Emerson Campbell, Graham Davis, John Emegbero Omakor, Adam Roger Moss, Ganesh Guhados
-
Patent number: 8476007Abstract: A biosensor having an optical fiber having at least one curved portion configured to enhance penetration of evanescent waves; and one or more nanoparticles associated with the optical fiber, and configured to enhance localized surface plasmon resonance.Type: GrantFiled: February 19, 2010Date of Patent: July 2, 2013Assignee: Indian Institute of Technology BombayInventors: Vemulakonda Venkata Raghavendra Sai, Soumyo Mukherji, Tapanendu Kundu
-
Patent number: 8476082Abstract: Devices and methods for the detection of target molecules are disclosed. Devices and methods for detecting food-borne target molecules are also disclosed.Type: GrantFiled: April 12, 2012Date of Patent: July 2, 2013Assignee: Invisible Sentinel, Inc.Inventors: Nicholas A. Siciliano, Martin Joseph Bouliane
-
Patent number: 8470609Abstract: A versatile drug testing device (a lateral flow diagnostic testing device) includes a flat transparent carrier with a top and a bottom with the carrier having a series of independent parallel grooves formed therein running from adjacent to the top to adjacent to the bottom of the carrier, each groove having a first opening and a second opening above the first opening therein adjacent to the bottom of the carrier, at least one drug test strip installed in one of said grooves with its absorbent pad contiguous to the openings and a cover layer attached to the carrier operable to sealing close each of said grooves whereby the bottom of the device can be immersed in a specimen of “urine”, “body fluid” or “other biological specimen” to wet the pad of the at least one test strip though the ingress of the specimen though the associated openings and the test results on the test strip can be easily viewed through the transparent carrier.Type: GrantFiled: September 11, 2007Date of Patent: June 25, 2013Inventor: Jian Feng Chen
-
Patent number: 8470610Abstract: Analytes in a sample are resolved by retentate chromatography in a procedure involving adsorbing the analytes on a substrate under a plurality of different selectivity conditions, and detecting the analytes retained on the substrate by desorption spectrometry. The methods are useful in biology and medicine, including clinical diagnostics and drug discovery.Type: GrantFiled: August 17, 2011Date of Patent: June 25, 2013Assignee: Bio-Rad Laboratories, Inc.Inventors: T. William Hutchens, Tai-Tung Yip
-
Patent number: 8470605Abstract: An optical reader for reading encoded microparticles. Each microparticle has an elongated body with an optically detectable code that extends along a longitudinal axis of the corresponding elongated body. The reader includes a plate that has a plurality of channels. The channels are configured to receive and align the microparticles so that the codes of the microparticles are in a common fixed orientation relative to each other. The reader also includes an illumination source for illuminating the microparticles on the plate. The codes in the microparticles reflect a portion of incident light and permit a portion of the incident light to pass through the microparticles thereby providing an output signal indicative of the code. The reader also includes a detection device that is configured to capture the output signal provided by the microparticles.Type: GrantFiled: March 20, 2009Date of Patent: June 25, 2013Assignee: Illumina, Inc.Inventors: Martin A. Putnam, Richard L. Lemoine
-
Patent number: 8465968Abstract: The present invention relates to a label-free biosensor system, a method for manufacturing said label-free biosensor system, its use for detecting biochemical reactions and/or bindings, enzymatic reactions, nucleic acid hybridizations, protein-protein interactions and protein-ligand interactions, as well as an assay method for detecting and/or quantifying an analyte of interest in a biological sample which comprises detecting the Recognition Induced Birefringence (RIB) generated in the presence as opposed to the absence of said analyte by bringing said sample into contact with said label-free biosensor system.Type: GrantFiled: December 22, 2009Date of Patent: June 18, 2013Assignee: DWI an der RWTH Aachen e.V.Inventors: Jürgen Groll, Martin Möller, Matthias Eberhardt
-
Patent number: 8465983Abstract: The invention relates to lipid bilayer coated beads and methods of using those beads in delivery systems, in immunoassays, in analytical assays and the like.Type: GrantFiled: August 21, 2006Date of Patent: June 18, 2013Inventors: Gabriel P. Lopez, Reema Zeineldin, Menake E. Piyasena, Sireesha Chemburu
-
Patent number: 8455255Abstract: The present invention presents a silica particle containing at least one silica compound selected from a group consisting of mercapto-propyl-trimethoxysilane (MPS), mercapto-propyl-triethoxysilane (MPES), mercapto-propyl-methyldimethoxysilane (MPDMS), trimethoxy[2-(7-oxabicyclo[4.1.0]-hepto-3-yl)ethyl]silane (EpoPS), thiocyanatopropyltriethoxysilane (TCPS), and acryloxypropyltrimethoxysilane (AcPS), which can be provided and utilized as a label, a marker, or the like for qualitative test and quantitative test for such as prophylactic agent, therapeutic agent, diagnostic agent, diagnostic and therapeutic agent or the like in dental, medical and veterinary fields regardless of fields.Type: GrantFiled: June 7, 2007Date of Patent: June 4, 2013Assignee: The University of TokushimaInventor: Michihiro Nakamura
-
Patent number: 8455265Abstract: A surface grafted conjugated polyelectrolyte (CPE) is formed by coupling a CPE by a coupling moiety to the surface of a substrate. The substrate can be of any shape and size, and for many uses of the surface grafted CPE, it is advantageous that the substrate is a nanoparticle or microparticle. Surface grafted CPEs are presented that use silica particles as the substrate, where a modified silane coupling agent connects the surface to the CPE by a series of covalent bonds. Two methods of preparing the surface grafted CPEs are presented. One method involves the inclusion of the surface being modified by the coupling agent and condensed with monomers that form the CPE in a grafted state to the substrate. A second method involves the formation of a CPE with terminal groups that are complimentary to functionality that has been placed on the surface of the substrate by reaction with a coupling agent. The surface grafted CPEs are also described for use as biosensors and biocides.Type: GrantFiled: February 29, 2008Date of Patent: June 4, 2013Assignee: STC.UNMInventors: David G. Whitten, Sireesha Chemburu, Thomas Corbitt, Linnea Ista, Gabriel Lopez, Kirk S. Schanze, Motokatsu Ogawa, Eunkyung Ji
-
Patent number: 8449833Abstract: The present invention provides a biosensor cartridge (11) comprising a bottom portion (1) with a well (2) adapted to accommodate a liquid sample and a cover portion (3) for closing said well (2). The well (2) has a sensor surface (4). The bottom portion (1) is adapted for allowing light to enter along a first optical path (5), to be reflected at the sensor surface (4) and to exit along a second optical path (6). The invention further relates to a method of manufacturing such a cartridge (11).Type: GrantFiled: October 24, 2008Date of Patent: May 28, 2013Assignee: Koninklijke Philips Electronics N.V.Inventor: Jeroen Hans Nieuwenhuis
-
Patent number: 8440468Abstract: Provided is a method for amplifying a frequency variation of a detected signal in a biosensor that is used for detecting a biomolecule by measuring a change in frequency of an oscillating signal, the change being caused by pressure a biomolecule applies to a piezoelectric substance. The method for amplifying a frequency variation of a detected signal comprises the steps of: (a) applying a sample to a probe being fixed to an upper portion of a substrate of the biosensor to allow a biomolecule in the sample to be bound to the probe; (b) applying protein tagged with a metal particle to the biosensor to allow the protein and the biomolecule to be bound with each other; and (c) applying a metal enhancer to the biosensor to allow the metal enhancer to be bound to the metal particle having been bound to the protein.Type: GrantFiled: April 9, 2008Date of Patent: May 14, 2013Assignee: Samsung Electronics Co., Ltd.Inventors: Hun Joo Lee, Soo Suk Lee
-
Patent number: 8415170Abstract: The invention provides a method for continuously detecting glucose concentration in a sample, including: (a) providing a biosensor comprising a transducer and a polysaccharide covered on the surface of the transducer; (b) providing a carbohydrate binding protein solution, wherein the carbohydrate binding protein has at least one receptor, and the receptor is capable of binding to the polysaccharide and glucose; (c) mixing a sample and the carbohydrate binding protein solution to form a mixture; (d) contacting the mixture with the biosensor; (e) detecting the amount of carbohydrate binding proteins bound to the polysaccharide by the biosensor, wherein glucose concentration of the sample is inversely proportional to the amount of carbohydrate binding proteins bound to the polysaccharide; and (f) refreshing the surface of the biosensor with a high concentration glucose solution.Type: GrantFiled: March 4, 2010Date of Patent: April 9, 2013Assignee: Industrial Technology Research InstituteInventors: Kun-Feng Lee, Chien-An Chen, Hong-Wen Chang, Yuh-Jiuan Lin
-
Patent number: 8414844Abstract: A portable, lightweight, rugged, easy-to-operate biosensor useful for rapidly detecting cells, viruses, antibodies, and other proteins. A capillary tube has a capture antibody immobilized on its interior surface. The specific capture antibody is selected based upon a desired target analyte to be detected. A sample potentially containing the target antigen is introduced into the capillary tube. Thereafter, a second antibody labeled with a fluorescent dye is introduced. Upon excitation by electromagnetic energy, typically supplied by a laser, the fluorescence of the sample is captured and analyzed. The apparatus is extremely compact and rugged making it ideal for field use. In addition, accurate results may be obtained by relatively unskilled operators directly from a self-contained readout. Optionally, an external device (e.g., a computer) may be connected to the apparatus via an optional interface.Type: GrantFiled: April 7, 2010Date of Patent: April 9, 2013Assignee: Research Foundation of State University of New YorkInventors: Omowunmi Sadik, Jason Karasinski
-
Patent number: 8409876Abstract: The present invention provides nanoparticle compositions comprising, for example, a core comprising a fluorescent silane compound; and a silica shell on the core. Also provided are methods for the preparation of nanoparticle compositions including fluorescent nanoparticles, ligated-fluorescent nanoparticles, ligated-fluorescent nanoparticles having therapeutic agents, and ligated-fluorescent nanoparticles coupled or associated with an analyte.Type: GrantFiled: October 14, 2009Date of Patent: April 2, 2013Assignee: Cornell Research Foundation, Inc.Inventors: Ulrich B. Wiesner, Hooisweng Ow
-
Patent number: 8405828Abstract: Devices, systems, kits, and methods for detecting and/or identifying a plurality of spectrally labeled bodies well-suited for performing multiplexed assays. By spectrally labeling the beads with materials which generate identifiable spectra, a plurality of beads may be identified within the fluid. Reading of the beads is facilitated by restraining the beads in arrays, and/or using a focused laser.Type: GrantFiled: November 17, 2009Date of Patent: March 26, 2013Assignee: Life Technologies CorporationInventors: Stephen Empedocles, Andrew Watson, Jian Jin
-
Patent number: 8404456Abstract: The present invention provides compositions and methods for treating or preventing antibody mediated graft rejection and blood typing.Type: GrantFiled: February 28, 2011Date of Patent: March 26, 2013Assignee: AbSorber ABInventors: Jan Holgersson, Jining Liu, Linda Lindberg, Per Grufman
-
Patent number: 8399262Abstract: Disclosed herein are biosensors for the detection of airborne biomolecules. The biosensors include a housing, a sensing component, and optionally a sample capture component. The biosensors may utilize a gel-based detection platform.Type: GrantFiled: August 2, 2011Date of Patent: March 19, 2013Inventors: Darrel A. Mazzari, Martin A. Seitz
-
Patent number: 8399208Abstract: The present invention is related to accurate detection methods for the measurement only of myeloperoxidase (MPO) levels or neutrophils, preferably equine neutrophils, in complex biological samples. The present invention is further related to ELISA and SIEFED assays for such detection. SIEFED detection sensitivity of active peroxidase activity was found to be enhanced by the addition of nitrite. Such MPO measurement finds its use in many applications such as the prediction, diagnosis and/or monitoring of pathologies correlated with neutrophil activation and/or destruction; the evaluation of drugs and/or immunomodulators; the assessment of immune responses, either natural and/or after treatment with immunomodulators and/or drugs; and the study of cells and their ability to fight microorganisms and/or to destroy them.Type: GrantFiled: February 7, 2005Date of Patent: March 19, 2013Assignee: Universite de LiegeInventors: Didier Serteyn, Ginette Dupont, Thierry Franck, Stéphane Kohnen
-
Patent number: 8399261Abstract: A lateral flow test system together with methods for its use in the detection of one or more analytes, or components, of interest within a sample, such as a biological sample, is provided. The system comprises a liquid formulation of a gold conjugate and a lateral flow assay device that does not include a conjugate pad having conjugate dried thereon.Type: GrantFiled: June 27, 2008Date of Patent: March 19, 2013Assignee: Inbios International, Inc.Inventors: Mazbahul Kabir, Syamal Raychaudhuri, James William Needham, Stanislaw Morkowski
-
Patent number: 8398935Abstract: A sheath flow system having a channel with at least one fluid transporting structure located in the top and bottom surfaces situated so as to transport the sheath fluid laterally across the channel to provide sheath fluid fully surrounding the core solution. At the point of introduction into the channel, the sheath fluid and core solutions flow side by side within the channel or the core solution may be bounded on either side by the sheath fluid. The system is functional over a broad channel size range and with liquids of high or low viscosity. A wide variety of shapes of fibers and other materials can be produced from this system through the use of polymerizable material.Type: GrantFiled: April 7, 2011Date of Patent: March 19, 2013Assignee: The United States of America, as represented by the Secretary of the NavyInventors: Peter B. Howell, Jr., Frances S. Ligler, Adam R. Shields
-
Patent number: 8394626Abstract: The present invention includes but is not limited to a specimen collection device that includes a chamber capable of collecting a specimen, a specimen passage slot, a reservoir, a reservoir seal, and a test device. A sample or specimen added to the chamber flows through the specimen passage slot into the reservoir. Flow into the reservoir may be limited by the reservoir seal. The test device positioned within the reservoir detects the presence or concentration of an analyte within the sample or specimen.Type: GrantFiled: June 2, 2009Date of Patent: March 12, 2013Assignee: Alere Switzerland GmbHInventors: James T. Ramsey, Larry Hartselle
-
Patent number: 8389229Abstract: Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, a method for immobilizing a lipoidal antigen, comprising cardiolipin, lecithin, and cholesterol, on a solid support (such as a nitrocellulose membrane) is described. The ability to immobilize a lipoidal antigen on a membrane satisfies a long-felt need for membrane-based assay for the detection of anti-lipoidal antibodies. Also described are immunoassay devices for concurrently performing treponemal and non-treponemal tests for syphilis.Type: GrantFiled: March 15, 2012Date of Patent: March 5, 2013Assignee: The United States of America as Represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and PreventionInventors: Arnold R. Castro, Robert W. George
-
Patent number: 8383422Abstract: The present invention provides an immunochromatographic device, which contains the following (a) and (b): (a) a first device part holding a first insoluble carrier used for developing a complex formed with an analyte and a labeling substance comprising a metal labeled with a first binding substance that can bind to the analyte and capturing the analyte and the labeling substance at a reaction portion containing a second binding substance that can bind to the analyte, and (b) a second device part holding a second insoluble carrier used for developing a liquid and a third insoluble carrier used for absorbing a liquid, in such a way that the first insoluble carrier does not come into contact with the second insoluble carrier and the third insoluble carrier.Type: GrantFiled: May 26, 2009Date of Patent: February 26, 2013Assignee: FUJIFILM CorporationInventors: Junichi Katada, Hideyuki Karaki, Takayoshi Oyamada
-
Patent number: 8383416Abstract: An optical sensor and method for use with a visible-light laser excitation beam and a Raman spectroscopy detector, for detecting the presence chemical groups in an analyte applied to the sensor are disclosed. The sensor includes a substrate, a plasmon resonance mirror formed on a sensor surface of the substrate, a plasmon resonance particle layer disposed over the mirror, and an optically transparent dielectric layer about 2-40 nm thick separating the mirror and particle layer. The particle layer is composed of a periodic array of plasmon resonance particles having (i) a coating effective to binding analyte molecules, (ii) substantially uniform particle sizes and shapes in a selected size range between 50-200 nm (ii) a regular periodic particle-to-particle spacing less than the wavelength of the laser excitation beam. The device is capable of detecting analyte with an amplification factor of up to 1012-1014, allowing detection of single analyte molecules.Type: GrantFiled: January 10, 2012Date of Patent: February 26, 2013Assignee: Vladimir PoponinInventor: Vladimir Poponin
-
Patent number: 8383423Abstract: A peptide-coated nanoparticle that includes a nanocrystal surrounded by a graded shell that is composed of at least two different semiconductor molecules. At least one peptide is attached to the surface of the graded shell to render the nanoparticle biocompatible. The nanocrystal core and graded shell are optionally annealed with ultra violet radiation prior to and/or after attachment of the peptide(s).Type: GrantFiled: March 29, 2011Date of Patent: February 26, 2013Assignee: The Regents of the University of CaliforniaInventors: Shimon Weiss, James M. Tsay, Fabien Pinaud, Soren Doose
-
Patent number: 8372592Abstract: The invention provides methods of detecting a change in cell growth patterns.Type: GrantFiled: September 22, 2011Date of Patent: February 12, 2013Assignee: X-Body, Inc.Inventors: Lance G. Laing, Rafael Fernandez, Rick Wagner
-
Patent number: 8367427Abstract: A method for processing multi-phasic dispersions is provided. The method comprises providing a multi-phasic dispersion including dispersed and continuous phases, providing one or more non-solvents comprising an aqueous solution containing at least one multivalent cation, exposing the multi-phasic dispersion to the non-solvent to form a suspension containing one or more liquid phases and the solid microparticles, and removing at least a portion of the resulting one or more liquid phases while retaining at least the microparticles, thereby removing at least a portion of the non-volatile material from the microparticles.Type: GrantFiled: August 20, 2008Date of Patent: February 5, 2013Assignees: Baxter International Inc., Baxter Healthcare S.A.Inventors: Ramin Darvari, Adam Lambert, Julia E. Rashba-Step, Mark X. Yang, Junhong Zhang, Ed O'Connell
-
Patent number: 8354280Abstract: The technology provided herein generally relates to reusable detection surfaces and methods for reusing a detection surface after using the detection surface in an assay for an analyte.Type: GrantFiled: September 5, 2008Date of Patent: January 15, 2013Assignee: BioScale, Inc.Inventors: Jaime E. Arenas, Hyun-Goo Choi, William Matthew Dickerson, Sarah Beth Hembree, Lara Louise Madison, Brett P. Masters, Michael F. Miller, Wayne U. Wang
-
Patent number: 8354238Abstract: A method of assaying a sample with the use of the aggregation reaction of immunological microparticles and an assay kit. The assay is conducted by using microparticles wherein the same or an analog of the analyte and a substance that specifically binds to a substance that can specifically bind to the analyte are both bound to an insoluble carrier. Thus, it becomes possible to conveniently carry out the assay even in the case where the analyte has only a small number of specific binding sites, without especially adding a competitive substance carrying hapten bonded thereto to the reaction system so as to induce simultaneous competition of the target substance and the competitive substance.Type: GrantFiled: November 10, 2008Date of Patent: January 15, 2013Assignee: Alfresa Pharma CorporationInventors: Mari Yanagiya, Mutsumi Tanaka, Mieko Kosaka, Masayasu Enomoto
-
Patent number: 8349611Abstract: Resonant sensors, preferably having floating bilayer symmetry, and their methods of use is determining the presence, amount or binding kinetics of an analyte of interest in a test sample are disclosed. The test sample may be a liquid or gas.Type: GrantFiled: February 17, 2010Date of Patent: January 8, 2013Assignee: Leversense LLCInventors: Jacob J. Loverich, Jeremy E. Frank, Peter A. Nagy
-
Patent number: 8343526Abstract: Disclosed are methods for conducting assays of samples, such as whole blood, that may contain cells or other particulate matter. Also disclosed are systems, devices, equipment, kits and reagents for use in such methods. One advantage of certain disclosed methods and systems is the ability to rapidly measure the concentration of an analyte of interest in blood plasma from a whole blood sample without blood separation and hematocrit correction.Type: GrantFiled: October 18, 2011Date of Patent: January 1, 2013Assignee: Meso Scale Technologies, LLCInventors: Mark A. Billadeau, Jeff D. Debad, Eli N. Glezer, Jonathan K. Leland, Charles A. Wijayawardhana
-
Patent number: 8343778Abstract: The invention encompasses microfluidic microarray assemblies (MMA) and subassemblies and methods for their manufacture and use. In one embodiment, first and second channel plates are provided and are sealingly connected to a test chip in consecutive steps. Each plate includes microfluidic channels configured in a predetermined reagent distribution pattern. The test chip comprises a plurality of discrete test positions, each test position being located at the intersection between a first predetermined reagent pattern and a second predetermined reagent pattern, wherein at least one of said patterns is non-linear. The first channel plate allows the distribution of a first reagent on said test chip, wherein said first reagent is immobilized at said test positions. The second channel plate allows the distribution of a second reagent on said test chip, wherein said second reagent comprises a plurality of different test samples.Type: GrantFiled: December 12, 2005Date of Patent: January 1, 2013Assignee: Simon Fraser UniversityInventors: Hua Zhong Yu, Meenakshinathan Parameswaren, Paul Chi Hang Li, Xing Yue Peng, Hong Chen, Wa Lok Chou
-
Patent number: 8343755Abstract: The invention relates to sensors for detecting chemical and biological material and for chemical actuation. In particular, the sensors of the present invention incorporates membranes or beams that are deformable in the presence of chemical adsorption on its surface. The sensor of the present invention contains a polymeric membrane or beam (102) that is clamped at least at two opposing ends (104) and (106).Type: GrantFiled: August 1, 2006Date of Patent: January 1, 2013Assignee: University of Virginia Patent FoundationInventors: Matthew R. Begley, James P. Landers, Jerome P. Ferrance, Ling Huang, Michael H. Jones, Marcel Utz, Scott Barker
-
Patent number: 8343440Abstract: A cancer cell separating apparatus includes: a flow channel including an antibody fixation area having antibodies which bind specifically to cancer cells fixed thereon, wherein the cancer cells and non-cancer cells are separated using a difference in velocity of movement between the cancer cells and the non-cancer cells in cell slurry introduced into the flow channel.Type: GrantFiled: March 23, 2010Date of Patent: January 1, 2013Assignee: Seiko Epson CorporationInventor: Satomi Yoshioka
-
Patent number: 8334107Abstract: The invention relates to lipid bilayer coated beads and methods of using those beads in immunoassays, in analytical assay and the like.Type: GrantFiled: April 7, 2009Date of Patent: December 18, 2012Assignee: STC.UNMInventors: Gabriel Lopez, Reema Zeineldin, Menake Piyasena
-
Patent number: 8323986Abstract: The present invention relates to a molecular assembly on a substrate usable for studying and/or performing biological interactions and/or reactions The invention further relates to an in vitro method to provide a substrate with a heparin coating presenting biotinylated biomolecules comprising linking avidin to a surface capable of binding avidin. A heparin conjugate is then linked to the avidin treated surface to form a layer of heparin thereon. Finally, a biotinylated biological probe or biomolecule is linked to the avidin through the layer of heparin thereby forming an essentially biologically inert surface with biotinylated probes extending out from the surface.Type: GrantFiled: September 28, 2007Date of Patent: December 4, 2012Assignee: Corline Systems ABInventors: Javier Sanchez, Rolf Larsson
-
Patent number: 8323882Abstract: Methods for forming cell arrays of multiple cell samples arranged substantially in a monolayer on a single substrate particularly suited for diagnostic analysis are disclosed. The cell arrays are formed with a high-speed dispensing apparatus capable of dispensing small volumes in precise, complex patterns. Also disclosed are substrates upon which cell arrays may be formed, and methods for conducting diagnostic analyses on the formed cell arrays.Type: GrantFiled: July 9, 2010Date of Patent: December 4, 2012Assignees: Biodot, Inc., Accupath Diagnostic Laboratories, Inc.Inventors: Mathew Moore, Miriam Reyes, David Baunoch, Thomas Tisone, Brendan O'Farrell
-
Patent number: 8318098Abstract: Embodiments of the present technique facilitate the detection of analytes. Detection is generally achieved by binding agents labeled with non-radiative energy transfer acceptors. The binding agents, when bound to a specific analyte, change conformation such that the distance between the respective non-radiative energy transfer acceptors and a respective quantum dot or quantum well changes. Certain embodiments of the present technique also comprise readout circuitry configured to determine rates of non-radiative energy transfer electrically and not optically.Type: GrantFiled: October 30, 2007Date of Patent: November 27, 2012Assignee: General Electric CompanyInventor: Rogerio Geraldes Rodrigues
-
Patent number: 8318492Abstract: The present invention relates in one aspect to a method for determining the cell culture history of a cell unit labelled with more than one type of tag comprising the steps of: (a) measuring one or more parameters of each tag that is used to label the cell unit; (b) identifying each tag in the cell unit; and (c) correlating the identity of each tag to the identity of the cell unit and/or the specific cell culture conditions to which the cell unit has been exposed.Type: GrantFiled: February 25, 2008Date of Patent: November 27, 2012Assignee: Plasticell LimitedInventors: Yen Choo, Fraser Hornby, John Girdlestone
-
Patent number: 8304203Abstract: A method and kit for assaying a cell sample for the presence of at least a threshold number of cells of a given type are disclosed. The kit includes an assay device having a sample chamber for receiving the cell sample and an elongate collection chamber containing a selected-density and/or viscosity medium and having along its length, a plurality of cell-collection regions, and particles which are capable of specific attachment to cells of the selected cell type, and which are effective, when attached to the cells, to increase the density or magnetic susceptibility of the cells. In operation, particle-bound cells and particles in the cell sample are drawn through the elongate collection chamber under the influence of a gravitational or selected centrifugal or magnetic-field force until the particle-bound cells and particles completely fill successive cell-collection regions in the collection chamber.Type: GrantFiled: December 5, 2008Date of Patent: November 6, 2012Assignee: Zyomyx, Inc.Inventors: Frank Zaugg, Renee Tobias, Silvia McManus-Munoz, Peter Kernen, Laurence Ruiz-Taylor, Peter Wagner
-
Patent number: 8298780Abstract: Methods are provided to detect changes in cells without the use of detection labels.Type: GrantFiled: December 15, 2008Date of Patent: October 30, 2012Assignee: X-Body, Inc.Inventors: Rick Wagner, Rafael Fernandez, Brian T. Cunningham, Lance Laing
-
Patent number: 8293542Abstract: The invention provides methods for detecting interactions between phage and antigen or antigen and antibody using biosensors.Type: GrantFiled: March 12, 2009Date of Patent: October 23, 2012Assignee: X-Body, Inc.Inventors: Lara Madison, John Gerstenmaier
-
Patent number: 8288157Abstract: A scanning sensor system, methods of use and kits for detecting a biologically active analyte are provided. The scanning sensor system includes a light source, a detector, a substrate comprising a plurality of waveguides and a plurality of optical sensing sites in optical communication with one or more waveguide of the substrate, and at least one adapter configured to couple with the substrate and provide optical communication between the light source, the waveguides of the substrate, and the detector.Type: GrantFiled: September 12, 2008Date of Patent: October 16, 2012Assignee: PLC Diagnostics, Inc.Inventor: Reuven Duer
-
Patent number: 8282896Abstract: Carriers or holders for holding microfluidic devices are provided. Some of the carriers that are provided include a hydration control device and/or a source of controlled fluid pressure to facilitate use of the carrier in conducting various types of analyses.Type: GrantFiled: October 5, 2009Date of Patent: October 9, 2012Assignee: Fluidigm CorporationInventors: Geoffrey Richard Facer, Hany Ramaz Nassef
-
Patent number: 8283156Abstract: The present invention relates to a method and apparatus for detecting analytes in a medium, and more particularly the present invention relates to an assay based on light diffraction which appears or changes upon the binding of analytes to their specific receptors laid out in patterns on a substrate, which has high sensitivity due to the appropriate choice of such patterns. The present invention is based on the principle that the pattern of recognition elements, which gives rise to the diffraction of the incident light in a diffraction-based assay, can be chosen in such a way so as to facilitate detection, and to enhance the signal to be detected compared to known gratings such as parallel straight lines. In one aspect the substrate itself has a surface topography designed to enhance the diffraction pattern signals. In another aspect the substrate is a diffractive optic element having the analyte-specific receptors affixed to the optic element.Type: GrantFiled: October 28, 2010Date of Patent: October 9, 2012Assignee: Axela Inc.Inventors: Cynthia M. Goh, Richard Loo, Jane B. Goh, Richard McAloney
-
Patent number: 8283185Abstract: The present invention includes a magnetically susceptible polymer component, a method of making the same, and apparatuses and systems for mixing, separating or localizing a magnetically susceptible polymer compound in a reaction. The magnetically susceptible polymer component includes a polymer and a magnetically susceptible particle of a predetermined size, which yields a component having a much-improved magnetic reactivity due to the increase in magnetic material by mass percentage. The apparatuses and systems of the present invention employ controllable magnetic fields distributable in perpendicular directions in order to precisely control the orientation, position and relative motion of any magnetically susceptible components within a reaction vessel.Type: GrantFiled: October 30, 2007Date of Patent: October 9, 2012Assignee: STC.UNMInventors: Bentley Paul, Davenport Michael
-
Patent number: RE43978Abstract: An electronic sensor is provided for detecting the presence of one or more analytes of interest in a sample. The sensor preferably comprises a field effect transistor in which conductance is enhanced altered by analyte binding to receptors in the active region. An array of sensors may be formed to analyze a sample for multiple analytes.Type: GrantFiled: September 23, 2008Date of Patent: February 5, 2013Assignee: University of HawaiiInventor: James W. Holm-Kennedy